Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.94M Buy
69,075
+235
+0.3% +$6.26K 0.93% 17
2025
Q4
$1.71M Sell
68,840
-346
-0.5% -$8.72K 0.83% 18
2025
Q3
$1.76M Buy
69,186
+2,614
+4% +$64.5K 0.84% 18
2025
Q2
$1.61M Sell
66,572
-2,475
-4% -$57.7K 0.81% 20
2025
Q1
$1.75M Buy
69,047
+664
+1% +$17.4K 0.99% 16
2024
Q4
$1.81M Sell
68,383
-14,336
-17% -$389K 0.86% 16
2024
Q3
$2.39M Sell
82,719
-11,572
-12% -$338K 1.11% 15
2024
Q2
$2.64M Sell
94,291
-11,165
-11% -$307K 1.25% 14
2024
Q1
$2.93M Buy
105,456
+208
+0.2% +$5.77K 1.39% 13
2023
Q4
$3.03M Buy
105,248
+284
+0.3% +$8.59K 1.48% 10
2023
Q3
$3.48M Buy
104,964
+998
+1% +$35.3K 2.23% 4
2023
Q2
$3.81M Buy
103,966
+1,748
+2% +$68K 2.44% 4
2023
Q1
$4.17M Sell
102,218
-18,985
-16% -$820K 2.66% 4
2022
Q4
$6.21M Buy
+121,203
New +$5.81M 3.47% 4
2020
Q3
$5.03M Hold
144,526
7.13% 2
2020
Q2
$4.48M Hold
144,526
4.82% 3
2020
Q1
$4.48M Sell
144,526
-35,934
-20% -$1.22M 6.92% 2
2019
Q4
$6.71M Buy
+180,460
New +$6.43M 6.3% 2

Other funds holding PFE

Horizon Bancorp's PFE Position: Q1 2026 in Review

Horizon Bancorp increased its Pfizer (PFE) stake by 0.34% in Q1 2026, buying an estimated $6.26K and bringing the position to 69,075 shares worth $1.94M. The position accounts for 0.93% of the portfolio, ranked #17.

Horizon Bancorp first reported a position in PFE in Q4 2019 and has held it in 18 quarters since. The position peaked at $6.71M in Q4 2019. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Horizon Bancorp held 69,075 shares of Pfizer worth $1.94M as of Q1 2026.
  • Horizon Bancorp bought 235 Pfizer shares in Q1 2026, an estimated $6.26K.
  • Pfizer made up 0.93% of Horizon Bancorp's portfolio in Q1 2026, its #17 holding.
  • Horizon Bancorp first reported a position in Pfizer in Q4 2019 and has held it in 18 quarters since.
  • Horizon Bancorp's Pfizer position peaked at $6.71M in Q4 2019.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Horizon Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.